New eye scan technology could revolutionize how doctors track vision disease
NCT ID NCT07347119
Summary
This study aims to develop better ways to measure and understand central serous chorioretinopathy (CSC), an eye condition that can cause vision problems. Researchers will use a special type of eye scan called ultra-widefield OCTA on 120 participants, including both CSC patients and healthy volunteers. The goal is to create detailed measurements of blood vessels in the eye that could help doctors track the disease and treatment response more accurately over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL SEROUS CHORIORETINOPATHY (CSC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.